We are live on ! Find out more
EW icon

Edwards Lifesciences
EW

1,295 hedge funds and large institutions have $45.6B invested in Edwards Lifesciences in 2024 Q2 according to their latest regulatory filings, with 122 funds opening new positions, 463 increasing their positions, 465 reducing their positions, and 90 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more first-time investments, than exits

New positions opened: 122 | Existing positions closed: 90

7% more funds holding in top 10

Funds holding in top 10: 14 → 15 (+1)

1% more funds holding

Funds holding: 1,279 → 1,295 (+16)

0.67% more ownership

Funds ownership: 81.25% → 81.93% (+0.67%)

0% less repeat investments, than reductions

Existing positions increased: 463 | Existing positions reduced: 465

2% less capital invested

Capital invested by funds: $46.6B → $45.6B (-$1.03B)

7% less call options, than puts

Call options by funds: $276M | Put options by funds: $297M

Holders
1,295
Holders Change
+16
Holders Change %
+1.25%
% of All Funds
18.7%
Holding in Top 10
15
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+7.14%
% of All Funds
0.22%
New
122
Increased
463
Reduced
465
Closed
90
Calls
$276M
Puts
$297M
Net Calls
-$21M
Net Calls Change
-$59.1M

Top Buyers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
+$348M
2
SFFS
Stonehage Fleming Financial Services
Jersey
+$204M
3
UBS AM
UBS AM
Illinois
+$137M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$122M
5
Swedbank
Swedbank
Sweden
+$109M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$224M
2
Citadel Advisors
Citadel Advisors
Florida
-$179M
3
BlackRock
BlackRock
New York
-$128M
4
JP Morgan Chase
JP Morgan Chase
New York
-$81.7M
5
State Street
State Street
Massachusetts
-$67.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
HL
1051
HeadInvest LLC
Maine
$212K – – –
LP
1052
LGL Partners
Pennsylvania
$212K +$203K +2,298 New
PL
1053
Perpetual Ltd
Australia
$212K -$16.2K -183 -7%
TPWA
1054
TRUE Private Wealth Advisors
Oregon
$210K +$1.95K +22 +1%
LAM
1055
L2 Asset Management
Massachusetts
$210K +$201K +2,272 New
AIM
1056
Acropolis Investment Management
Missouri
$209K +$266 +3 +0.1%
Parallax Volatility Advisers
1057
Parallax Volatility Advisers
California
$209K -$1.24M -14,032 -86%
PIA
1058
Powell Investment Advisors
Florida
$209K – – –
MWM
1059
Modera Wealth Management
New Jersey
$208K +$199K +2,252 New
CWM
1060
Cornerstone Wealth Management
Missouri
$208K +$13K +147 +7%
VVP
1061
Venture Visionary Partners
Ohio
$207K +$198K +2,239 New
TCOV
1062
Trust Company of Vermont
Vermont
$205K +$2.21K +25 +1%
MSR
1063
Main Street Research
Connecticut
$204K +$1.15K +13 +0.6%
NAM
1064
NorthCrest Asset Manangement
Minnesota
$204K – – –
VI
1065
Versor Investments
New York
$203K -$381K -4,300 -66%
AWM
1066
Activest Wealth Management
Florida
$203K +$195K +2,200 New
BBA
1067
Braun-Bostich & Associates
Pennsylvania
$203K -$123K -1,389 -39%
JWM
1068
Jeppson Wealth Management
California
$202K -$886 -10 -0.5%
HWA
1069
Heritage Wealth Advisors
Virginia
$191K – – –
CB
1070
CNB Bank
Pennsylvania
$190K -$22.8K -257 -11%
AT
1071
Avalon Trust
New Mexico
$189K -$55.3K -625 -23%
AF
1072
Advisornet Financial
Minnesota
$187K – – –
PAS
1073
Point72 Asia (Singapore)
Singapore
$182K +$175K +1,971 New
CH
1074
Cromwell Holdings
Wyoming
$179K +$171K +1,933 New
HI
1075
Hendershot Investments
Virginia
$178K -$15.1K -171 -8%
41 42
43
44 45

EW Hedge Fund Activity: Q2 2024 in Review

1,295 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q2 2024, worth a combined $45.6B — down 2.2% from $46.6B a quarter earlier.

Buyers outnumbered sellers: 122 funds opened new EW positions and 90 closed out — a net gain of 32 holders — while 463 added to existing stakes and 465 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $348M. The largest seller was Point72 Asset Management, cutting an estimated $224M.

  • 1,295 institutional investors held Edwards Lifesciences (EW) as of Q2 2024, up from 1,279 in Q1 2024.
  • Funds reported $45.6B of Edwards Lifesciences stock for Q2 2024, down 2.2% quarter-over-quarter.
  • 122 funds opened new Edwards Lifesciences positions in Q2 2024 and 90 closed out, a net change of +32 holders.
  • The largest Edwards Lifesciences buyer in Q2 2024 was AllianceBernstein, an estimated $348M added.
  • The largest Edwards Lifesciences seller in Q2 2024 was Point72 Asset Management, an estimated $224M sold.

Based on aggregated 13F filings for Q2 2024.